Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
0.6469
-0.2681 (-29.30%)
At close: Sep 17, 2025, 4:00 PM EDT
0.6400
-0.0069 (-1.07%)
After-hours: Sep 17, 2025, 7:59 PM EDT
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $2.10 million as of September 17, 2025. Its market cap has decreased by -53.02% in one year.
Market Cap
2.10M
Enterprise Value
-649.92K
1-Year Change
-53.02%
Ranking
Category
Stock Price
$0.65
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $11.31B to $2.10M, a decrease of -99.98%. That is a compound annual growth rate of -83.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 2.97M | -18.51% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.74% |
| Dec 31, 2020 | 11.31B | - |
| Dec 31, 2020 | 11.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |